The latest closing stock price for Relmada Therapeutics as of November 08, 2024 is 3.28.
An investor who bought $1,000 worth of Relmada Therapeutics stock at the IPO in 2019 would have $-708 today, roughly -1 times their original investment - a -21.85% compound annual growth rate over 5 years.
The all-time high Relmada Therapeutics stock closing price was 50.12 on February 26, 2020.
The Relmada Therapeutics 52-week high stock price is 7.22, which is 120.1% above the current share price.
The Relmada Therapeutics 52-week low stock price is 1.88, which is 42.7% below the current share price.
The average Relmada Therapeutics stock price for the last 52 weeks is 3.69.
An investor who bought $1,000 worth of Relmada Therapeutics stock at the IPO in 2019 would have $-708 today, roughly -1 times their original investment - a -21.85% compound annual growth rate over 5 years.
The all-time high Relmada Therapeutics stock closing price was 50.12 on February 26, 2020.
The Relmada Therapeutics 52-week high stock price is 7.22, which is 120.1% above the current share price.
The Relmada Therapeutics 52-week low stock price is 1.88, which is 42.7% below the current share price.
The average Relmada Therapeutics stock price for the last 52 weeks is 3.69.